Pelaia, G. et al. 2014. Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium. Multidisciplinary Respiratory Medicine. 9, 1 (Dec. 2014). DOI:https://doi.org/10.4081/mrm.2014.399.